737 related articles for article (PubMed ID: 28415828)
1. Melatonin for the prevention and treatment of cancer.
Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
[TBL] [Abstract][Full Text] [Related]
2. The emergence of melatonin in oncology: Focus on colorectal cancer.
Gil-Martín E; Egea J; Reiter RJ; Romero A
Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
[TBL] [Abstract][Full Text] [Related]
3. Melatonin and its ubiquitous anticancer effects.
Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
5. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
[TBL] [Abstract][Full Text] [Related]
6. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
[TBL] [Abstract][Full Text] [Related]
8. Potential role of melatonin in prevention and treatment of leukaemia.
Ng MG; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):445-461. PubMed ID: 34355548
[TBL] [Abstract][Full Text] [Related]
9. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.
Talib WH; Alsayed AR; Abuawad A; Daoud S; Mahmod AI
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923028
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
Xi SC; Siu SW; Fong SW; Shiu SY
Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
[TBL] [Abstract][Full Text] [Related]
11. Melatonin as a treatment for gastrointestinal cancer: a review.
Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
[TBL] [Abstract][Full Text] [Related]
12. Oncostatic action of melatonin: facts and question marks.
Pawlikowski M; Winczyk K; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
[TBL] [Abstract][Full Text] [Related]
13. Melatonin: A Potential Therapeutic Option for Breast Cancer.
Kong X; Gao R; Wang Z; Wang X; Fang Y; Gao J; Reiter RJ; Wang J
Trends Endocrinol Metab; 2020 Nov; 31(11):859-871. PubMed ID: 32893084
[TBL] [Abstract][Full Text] [Related]
14. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
Samanta S
Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.
Das A; Wallace G; Reiter RJ; Varma AK; Ray SK; Banik NL
J Pineal Res; 2013 Jan; 54(1):58-68. PubMed ID: 22823500
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
[TBL] [Abstract][Full Text] [Related]
17. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.
Bondy SC; Campbell A
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060531
[TBL] [Abstract][Full Text] [Related]
19. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
[TBL] [Abstract][Full Text] [Related]
20. Distribution of melatonin receptors in murine pancreatic islets.
Nagorny CL; Sathanoori R; Voss U; Mulder H; Wierup N
J Pineal Res; 2011 May; 50(4):412-7. PubMed ID: 21355877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
